Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
2016
The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
2013
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Cigarette Smoking and Progression of Atherosclerosis
1998
Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
2008
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
2010
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Ion Transport Pathology in the Mechanism of Sickle Cell Dehydration
2004
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
2014
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
2016
High-Density Lipoprotein as a Therapeutic Target
2007
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study
2002
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
2005
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
2017
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Retinal and Optic Nerve Head Pathology in Susac's Syndrome
2010
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels
2013 StandoutNobel
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
2013
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
2013
Incidental Findings on Brain MRI in the General Population
2007 Standout
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study
2003
Analysis and Monitoring of Oxidative Stress in Exercise and Training by FTIR Spectrometry
2008
Design of a novel class of biphenyl CETP inhibitors
2010
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Retinal Arteriolar Narrowing and Risk of Coronary Heart Disease in Men and Women
2002
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
The “All of Us” Research Program
2019 Standout
Type 2 diabetes
2017 Standout
Update on strategies to increase HDL quantity and function
2009
ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia
2009
Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atheroscierosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study
1999
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
2007
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Variability in B-mode ultrasound measurements in the Atherosclerosis Risk in Communities (ARIC) study
1996
Retinal microvascular abnormalities and 10-year cardiovascular mortality
2003
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease
2006
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
2011
Retinal Microvascular Abnormalities and their Relationship with Hypertension, Cardiovascular Disease, and Mortality
2001
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
2014
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Cerebral White Matter Lesions, Retinopathy, and Incident Clinical Stroke
2002
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study
2002
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine
2008 Standout
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells†,‡
2005
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
Homocysteine and Atherothrombosis
1998 Standout
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
2011
Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
1997 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies
2007
Prevalence of Asymptomatic Carotid Atherosclerotic Lesions Detected by High-Resolution Ultrasonography and Its Relation to Cardiovascular Risk Factors in the General Population of a Japanese City
1997
Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
1993
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( CANVAS‐R ): A randomized, placebo‐controlled trial
2017
Inhibition of the Endogenous Volume-regulated Anion Channel (VRAC) in HEK293 Cells by Acidic Di-Aryl-Ureas
2003
Arterial Wall Thickness Is Associated With Prevalent Cardiovascular Disease in Middle-Aged Adults
1995
Atherosclerosis Drug Development in Jeopardy: The Need for Predictive Biomarkers of Treatment Response
2011
Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study
1997
Cigarette Smoking and Other Risk Factors for Silent Cerebral Infarction in the General Population
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Orthostatic Hypotension Predicts Mortality in Middle-Aged Adults
2006
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
1993
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
2003
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness
2007 Standout
The Gárdos channel: a review of the Ca2+-activated K+ channel in human erythrocytes
2003
Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes
1995
Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease
1997
Hypertensive Retinal Vessel Wall Signs in a General Older Population
2003
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins
1998
Relationship of Periodontal Disease to Carotid Artery Intima-Media Wall Thickness
2001
Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes
2000 Standout
Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study
1994
Insulin Sensitivity and Atherosclerosis
1996
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
1994
Works of Greg Evans being referenced
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
2005
Carotid Wall Thickness is Predictive of Incident Clinical Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
2000
Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
2007
Risk Factors and Segment-Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort
1996
Are Retinal Arteriolar Abnormalities Related to Atherosclerosis?
2000
High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort
1991
Intensive glucose control and macrovascular outcomes in type 2 diabetes
2009
Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease
2001
Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack.
1991